A Multicenter, Prospective, Post Marketing Surveillance study ofAripiprazole tablet in Adolescent patients with Schizophrenia

Torrent Pharmaceuticals Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Male or female adolescent patients aged 13 to 17 years (both inclusive)
•2. Patients diagnosed with schizophrenia according to the International Classification of Diseases (ICD) and who as per investigator discretion need aripiprazole therapy

•1. Patients with known hypersensitivity to aripiprazole.
•2. Patients with concurrent psychiatric comorbidity requiring pharmacotherapy and/or
•medications.
•3. Any evidence of suicide risk; or a history or current diagnosis of schizoaffective disorder,
•mental retardation, major depressive episodes, neuroleptic malignant syndrome, any
•neurologic disorder other than Tourettes syndrome, severe head trauma, or any unstable
•medical condition
•4. Pregnant or lactating and sexually active adolescent boys or adolescent girls who do not
•agree to abstinence or birth control
•5. In the opinion of the investigator patient is either unable to cooperate or unlikely to
•adhere with any study procedures

发起方